Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (12 ops.)
Latest filing published 02 Mar 2026 for ANI Pharmaceuticals INC, €726k. Read the official filing
Filing timeline
BuySaleChad Gassert
Insider track record
Disclosed buys
1
Disclosed sells
12
T+90 hit rate
100%
T+90 mean return
+16.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Chad Gassert: trading record in brief
Chad Gassert (senior executive) discloses dealings in ANI Pharmaceuticals Inc to SEC (Form 4). In total, 24 filings cover trades dated from 19 November 2021 to 26 February 2026.
Both buying and selling appear: 1 purchase worth €122k, against 12 sales worth €13.8M. The net balance comes to €13.7M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 11 share grants.
The latest filing, published on 2 March 2026, reports a share grant of €726k in ANI Pharmaceuticals Inc. The latest purchase dates back some time: it was published 1,671 days ago, on 22 March 2022. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Chad Gassert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
11,116 shares@ US$77.154.8% of flowCommon StockSEC:0001871002-26-000006:0
1,608 shares@ US$76.700.9% of flowCommon StockSEC:0001871002-26-000004:0
1,717 shares@ US$77.361.0% of flowCommon StockSEC:0001871002-26-000004:1
4,269 shares@ US$76.251.8% of flowCommon StockSEC:0001871002-26-000002:0
14,642 shares@ US$89.077.9% of flowCommon StockSEC:0001871002-25-000007:0
20,000 shares@ US$86.9711.4% of flowCommon StockSEC:0001871002-25-000004:0
14,362 shares0Common StockSEC:0001871002-25-000002:0
9,574 shares0Common StockSEC:0001871002-25-000002:1
20,000 shares@ US$63.4410.2% of flowCommon StockSEC:0001871002-24-000014:0
20,000 shares@ US$64.4110.2% of flowCommon StockSEC:0001871002-24-000012:0
20,000 shares@ US$66.6210.7% of flowCommon StockSEC:0001871002-24-000010:0
20,000 shares@ US$67.2510.8% of flowCommon StockSEC:0001871002-24-000008:0
20,000 shares@ US$65.8110.4% of flowCommon StockSEC:0001871002-24-000006:0
1,635 shares@ US$67.670.9% of flowCommon StockSEC:0001871002-24-000004:0
13,421 shares0Common StockSEC:0001871002-24-000002:0
20,000 shares@ US$56.489.3% of flowCommon StockSEC:0001871002-23-000009:0
20,000 shares@ US$64.7010.3% of flowCommon StockSEC:0001871002-23-000006:0
20,000 shares@ US$51.068.0% of flowCommon StockSEC:0001871002-23-000004:0
20,000 shares@ US$53.438.4% of flowCommon StockSEC:0001104659-23-078742:0
20,000 shares@ US$51.328.1% of flowCommon StockSEC:0001104659-23-074398:0
17,369 shares0Common StockSEC:0001104659-23-041729:0
11,578 shares0Common StockSEC:0001104659-23-041729:1
5,000 shares@ US$27.14880.8% of flowCommon StockSEC:0001415889-22-003267:0
Canonical exit: 16 Jun 2022 (T+90)
383,226 sharesCommon StockSEC:0001415889-21-005442:0
24 of 24 declarations
